Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: Comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen

  1. Jarrin, I.
  2. Hernández-Novoa, B.
  3. Alejos, B.
  4. Santos, I.
  5. Lopez-Aldeguer, J.
  6. Riera, M.
  7. Gutiérrez, F.
  8. Rubio, R.
  9. Antela, A.
  10. Blanco, J.R.
  11. Moreno, S.
Zeitschrift:
HIV Medicine

ISSN: 1468-1293 1464-2662

Datum der Publikation: 2014

Ausgabe: 15

Nummer: 9

Seiten: 547-556

Art: Artikel

DOI: 10.1111/HIV.12144 GOOGLE SCHOLAR lock_openOpen Access editor